Related Experiment Video
Updated: Jun 21, 2026
07:43
Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
Published on: February 8, 2017
26.6K
Symptomatic brain metastases in melanoma.
Andrea Knox1, Tim Wang2, Mark Shackleton1,3
1Department of Medical Oncology, Alfred Health, Melbourne, Australia.
Experimental Dermatology
|April 13, 2024
Summary
Managing symptomatic melanoma brain metastases (MBM) remains difficult, with poorer outcomes than asymptomatic MBM. This review covers challenges, treatments, and future research for symptomatic MBM.
Area of Science:
- Oncology
- Neurology
- Dermatology
Background:
- Metastatic melanoma treatment has advanced, but symptomatic brain metastases present significant challenges.
- Melanoma brain metastases (MBM) in symptomatic patients have inferior response rates and survival compared to asymptomatic patients.
Purpose of the Study:
- To review the specific challenges in managing symptomatic melanoma brain metastases (MBM).
- To discuss current treatment strategies, obstacles, and future research directions for symptomatic MBM.
Main Methods:
- Literature review of current treatment paradigms for symptomatic melanoma brain metastases.
- Analysis of obstacles hindering improved clinical outcomes.
- Identification of future research directions.
Main Results:
- Symptomatic MBM patients face poorer prognoses than asymptomatic MBM patients.
- Current management strategies for symptomatic MBM are discussed, highlighting existing obstacles.
Conclusions:
- Despite advances in metastatic melanoma care, symptomatic MBM remain a critical clinical challenge.
- Further research is needed to overcome obstacles and improve outcomes for patients with symptomatic MBM.
